10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 254 filers reported holding 10X GENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $225,891 | -0.3% | 4,060 | 0.0% | 0.04% | -10.9% |
| Q1 2023 | $226,507 | +13.0% | 4,060 | 0.0% | 0.05% | +17.9% |
| Q4 2022 | $200,379 | -38.9% | 4,060 | -5.8% | 0.04% | -26.4% |
| Q1 2022 | $328,000 | -49.0% | 4,310 | 0.0% | 0.05% | -41.8% |
| Q4 2021 | $643,000 | +2.1% | 4,310 | +0.2% | 0.09% | -1.1% |
| Q3 2021 | $630,000 | -58.8% | 4,300 | -44.9% | 0.09% | -42.5% |
| Q2 2021 | $1,529,000 | +46.9% | 7,800 | +35.7% | 0.16% | -0.6% |
| Q1 2021 | $1,041,000 | -46.5% | 5,750 | -58.2% | 0.16% | -49.2% |
| Q4 2020 | $1,947,000 | +22.4% | 13,750 | +7.8% | 0.32% | -3.6% |
| Q3 2020 | $1,591,000 | +39.7% | 12,750 | 0.0% | 0.33% | +5.8% |
| Q2 2020 | $1,139,000 | – | 12,750 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |